Peter van der Velden is 10% Owner at Edesa Biotech, Inc. (EDSA). They have made 1 open-market trade across 1 company since 2023, most recently 2023-01-10.
CIK 0001778046
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EDSA | 1,625,133 | $4.1M |
Shares reported on the most recent Form 4, priced at the 2023-01-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDSA | SELL | 2023-01-09 | 2023-01-11 | $2.64 | $1.5M | -43.0% | -42.6% | -61.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.